QVCG is at the centre of a significant ownership reshuffle, with GoldenTree Asset Management pressing its activist case just as Silver Point Capital appears to be unwinding its stake — a divergence that tells sharply different stories about where two sophisticated investors see value in QVC Group Inc.
The activist angle is the week's standout. GoldenTree filed a Schedule 13D/A on September 10, lifting its disclosed stake to 22% of the class from 18.8% — the third filing since its initial 13D in mid-August, a rapid escalation that signals active and intensifying engagement. The dollar amounts are concrete: on September 8 alone, GoldenTree bought 1.6 million shares at $16.25, a $26 million open-market purchase made without the cover of a 10b5-1 plan. The buying continues a streak that runs back through late August, with smaller purchases on August 25-28 and another $11.8 million tranche on September 3. Net insider buying across the last 90 days totals roughly $11.2 million on a net basis, but the gross purchases from GoldenTree are materially larger. GoldenTree now holds approximately 17.3% of shares per institutional data, with the 13D disclosure carrying the higher 22% figure — the difference reflecting timing and reporting lags. Per standard disclosure rules, the 13D stake is "as last disclosed" and positions can move without a further filing unless they cross key thresholds again.
Sitting directly on the other side of the GoldenTree trades is Silver Point Capital, which matched GoldenTree's September 8 purchase with a 1.6 million share sale at the same price, and mirrored the September 3 transaction too. Barclays PLC's separate 13G/A filing, dated September 8, shows its stake falling sharply to 3.36% from 10.21% — a near-complete exit from the register. The concentrated ownership picture has shifted materially in a matter of weeks: the top nine institutional holders now account for essentially the entire float, with Strategic Value Special Situations, GoldenTree, Silver Point, and Brookfield together controlling roughly 68% of shares. As Silver Point rotates out and GoldenTree absorbs the stock, the effective free float is shrinking.
The lending market reflects this concentration. Borrow availability is exceptionally loose at 6,384% — meaning there are roughly 64 shares available to borrow for every one currently lent out — and short interest has collapsed by 64% in one week to around 175,000 shares. That is a tiny position for a stock of this profile, and cost to borrow at 3.9% has more than halved from the 10-13% range seen in late August. The brief August 31 spike, when availability tightened sharply to around 818% and utilization hit its 52-week high of 21.7%, appears to have been a transient squeeze as the Silver Point/GoldenTree block trades cleared. The lending market now reflects minimal short conviction: there is no meaningful squeeze risk and no borrow premium to suggest organised short positioning is building.
The stock itself has been a difficult hold for most investors. Shares are up around 0.8% on the week and 2.9% over the past month to $16.85, but a prior note flagged a roughly 47% year-to-date decline — context that explains why GoldenTree's activist posture attracted attention. Valuation data is thin, with an enterprise value around $6.1 billion but limited forward multiples on file. Factor scores add limited colour: a days-to-cover rank in the 87th percentile reflects the concentrated float dynamics more than genuine short pressure. The dividend history is stale — the last regular payout disclosed was a special cash dividend in November 2021.
What to watch is whether GoldenTree files a fourth 13D amendment, which would indicate the activist stake continues to build past 22%, and whether Silver Point's exit is now complete or represents only a partial reduction of its 17.2% institutional position.
See the live data behind this article on ORTEX.
Open QVCG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
